Company

Mirum Pharmaceuticals, Inc. (MIRM)

Standardized SEC financial data for Mirum Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001759425 · NASDAQ · Pharmaceutical Preparations.

Operating margin

-4.3%

Net margin

-4.5%

Revenue growth (YoY)

54.7%

Return on equity

-7.4%

Free cash flow

$54.9M

Current ratio

2.67×

EPS (diluted)

$-0.47

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$0	$19.1M	$77.1M	$186.4M	$336.9M	$521.3M
R&D expense	$81.6M	$131.4M	$106.8M	$102.6M	$140.6M	$186.2M
SG&A expense	$22.7M	$59.2M	$89.1M	$145.9M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$142.1M	$31.3M	$28.0M	$286.3M	$222.5M	$296.7M
Inventory	$0	$1.5M	$5.6M	$22.3M	$22.4M	$24.9M
Total current assets	$236.3M	$166.6M	$190.2M	$387.5M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$89.1M	-$132.8M	-$120.1M	-$70.9M	$10.3M	$55.8M
Capital expenditures	$225K	$24K	$278K	$109K	$993K	$954K
Free cash flow	-$89.3M	-$132.8M	-$120.4M	-$71.1M

Get MIRM data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MIRM/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MIRM/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View MIRM filings on SEC EDGAR →